WEXFORD CAPITAL LP - CATABASIS PHARMACEUTICALS IN ownership

CATABASIS PHARMACEUTICALS IN's ticker is and the CUSIP is 14875P206. A total of 64 filers reported holding CATABASIS PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is 0.59 and the average weighting 0.0%.

Quarter-by-quarter ownership
WEXFORD CAPITAL LP ownership history of CATABASIS PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2020$42,00019,5120.01%
Other shareholders

There were no reported owners of CATABASIS PHARMACEUTICALS IN in Q4 2020.

NameSharesValueWeighting ↓
View complete list of CATABASIS PHARMACEUTICALS IN shareholders